Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEA RNA-pulsed Dendritic Cells in Metastatic Breast Cancer
NCT00003432Phase 2Terminated
- Sponsor
- Duke University
- Start
- Jun 1998
- Primary completion
- Nov 2002
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines, RNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of carcinoembryonic antigen RNA-pulsed dendritic cell vaccine in breast cancer, sponsored by Duke University. Started Jun 1998; status: terminated.
02
Drugs
carcinoembryonic antigen RNA-pulsed dendritic cell vaccine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003432.